News | January 24, 2026
Akums bags key EU GMP certifications for 2 Haridwar plants
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
The state-of-the-art facility is expected to be commissioned over the next three years
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Subscribe To Our Newsletter & Stay Updated
